Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
Thriemer K. et al, (2023), BMC Medical Research Methodology, 23
Severe falciparum malaria in pregnancy in Southeast Asia: a multi-centre retrospective cohort study.
Saito M. et al, (2023), BMC medicine, 21
Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021
Tam NT. et al, (2023), Emerging Infectious Diseases, 29
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2023), medRxiv
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.
Trimarsanto H. et al, (2022), Communications biology, 5
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Dahal P. et al, (2022), Malaria Journal, 21
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia
Cutts JC. et al, (2022), The Journal of Infectious Diseases, 226, 324 - 331
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
Adam I. et al, (2022), Wellcome Open Research, 7, 136 - 136
Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study
O’Flaherty K. et al, (2022), Frontiers in Cellular and Infection Microbiology, 12
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
Zhu L. et al, (2022), Communications Biology, 5
Quantitative bacterial counts in the bone marrow of Vietnamese patients with typhoid fever.
Van Be Bay P. et al, (2022), Transactions of the Royal Society of Tropical Medicine and Hygiene
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
MalariaGEN None. et al, (2022), Wellcome open research, 7
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Vélez ID. et al, (2021), Lancet Child Adolesc Health
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Mukaka M. et al, (2021), Malaria Journal, 20
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children.
Han AX. et al, (2021), eLife, 10
The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam
Thai PQ. et al, (2021), Clinical Infectious Diseases, 72, e334 - e342
Development of Weight and Age-based Dosing of Daily Primaquine for Radical Cure of Vivax Malaria
Taylor WR. et al, (2021)